DOCSLIB.ORG

Forskningsorganisasjon - Definisjon Og Godkjente Organisasjoner

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Forskningsorganisasjon - Definisjon Og Godkjente Organisasjoner Versjon 7.02.2019 Forskningsorganisasjon - definisjon og godkjente organisasjoner Følgende organisasjoner er godkjent som forskningsorganisasjon av Forskningsrådet og kan være prosjektansvarlig og/eller samarbeidspartner i søknader og prosjekter der det er krav om at disse skal være godkjente forskningsorganisasjoner (se vedlegg for detaljer/navn) • Universiteter, vitenskapelige høyskoler, høyskoler akkreditert på institusjonsnivå av NOKUT. • Helseforetak/sykehus med lovpålagte oppgaver innen forskning og utvikling og private, ideelle sykehus som inngår i Helse- og omsorgsdepartementets (HOD) målesystem for forskning. • Forskningsorganisasjoner underlagt Retningslinjer for statlig basisfinansiering av forskningsinstitutter. • Andre organisasjoner som har forskning som formål og som er vurdert og godkjent etter statsstøtteregelverkets definisjon og en helhetsvurdering foretatt av Forskningsrådet Andre organisasjoner kan søke om å bli godkjent av Forskningsrådet, og vil bli vurdert og godkjent etter Forskningsrådets retningslinjer for godkjenning av forskningsorganisasjoner: En forskningsorganisasjon er en enhet, uavhengig av rettslig status (offentlig- eller privatrettslig) eller finansieringsmåte, som har som hovedformål å drive med uavhengig forskning i form av grunnforskning og/eller anvendt forskning (industriell forskning og eksperimentell utvikling). Organisasjonen skal være registrert i Enhetsregisteret med eget organisasjonsnummer. Når organisasjonen også driver med økonomisk aktivitet, skal det være separat regnskapsførsel av den økonomiske og den ikke-økonomiske aktiviteten. Det kan ikke betales utbytte fra organisasjonens aktiviteter, og foretak som har avgjørende innflytelse på virksomheten, f.eks. som aksjeeiere eller medlemmer, skal ikke ha særskilt adgang til resultatene organisasjonen oppnår. I en forskningsorganisasjon må minimum 10% av årsverkene, dog minst 5 årsverk, være FoU-årsverk En enhet som er klassifisert som forskningsorganisasjon av Forskningsrådet, kan ikke også opptre som bedrift i søknader til Forskningsrådet. En offentlig enhet som er klassifisert som forskningsorganisasjon, kan opptre både som offentlig enhet og som forskningsorganisasjon i søknader til Forskningsrådet, dog ikke innenfor samme søknadstype i samme utlysning. TTO´er (Technology Transfer Office) kan søke på enkelte av Forskningsrådets utlysninger, der det er oppgitt at utlysningen er rettet mot disse. Forskningsrådets definisjon av forskningsorganisasjon fraviker noe fra EUs definisjon, fordi Forskningsrådet bl a må forholde seg til ESA og statsstøtteregelverket. Versjon 7.02.2019 Søknad om godkjenning som forskningsorganisasjon Søknad om godkjenning som forskningsorganisasjon sendes til [email protected] Søknaden skal inneholde følgende opplysninger: • organisasjonens vedtekter • regnskap fra de siste tre regnskapsårene med revisors beretning • utskrift fra Brønnøysundregisteret (firmaattest) • redegjørelse for at organisasjonen driver uavhengig forskning, f.eks. med en oversikt over slik forskning utført de siste tre år med finansieringskilde og beløp • oversikt over FoU-årsverk og antall ansatte • redegjørelse for hvorvidt organisasjonen har et allmennyttig formål, inkludert om den reinvesterer all fortjeneste i organisasjonens aktivitet • dokumentere at eier eller nærstående ikke gis direkte eller indirekte fordeler Versjon 7.02.2019 Vedlegg 1: Oversikt over forskningsorganisasjoner Listen nedenfor gir en oversikt over organisasjoner som er godkjent som forskningsorganisasjoner etter Forskningsrådets kriterier. Organisasjonenes underliggende enheter vil også forstås som forskningsorganisasjoner. Organisasjoner som ikke står oppført i denne listen må søke Forskingsrådet om å bli vurdert som forskningsorganisasjoner etter Forskningsrådets kriterier. 1. Universiteter og høgskoler 1.1 Universiteter norsk engelsk Nord universitet Nord University Norges arktiske universitet (UiT) The Arctic University of Norway (UiT) Norges miljø- og biovitenskapelige universitet Norwegian University of Life Sciences (NMBU) (NMBU) Norges teknisk-naturvitenskapelige universitet The Norwegian University of Science and (NTNU) Technology (NTNU) OsloMet – Storbyuniversitetet OsloMet – Oslo Metropolitan University Universitetet i Agder (UiA) The University of Agder (UiA) Universitetet i Bergen (UiB) The University of Bergen (UiB) Universitetet i Oslo (UiO) The University of Oslo (UiO) Universitetet i Stavanger (UiS) The University of Stavanger (UiS) Universitetet i Sørøst-Norge (USN) The University of South-Eastern Norway (USN) Universitetssenteret på Svalbard (UNIS) The University Centre in Svalbard (UNIS) 1.2 Vitenskapelige høgskoler norsk engelsk Arkitektur- og designhøgskolen i Oslo The Oslo School of Architecture and Design Handelshøyskolen BI Norwegian School of Management BI Norges Handelshøyskole (NHH) Norwegian School of Economics (NHH) Norges idrettshøgskole The Norwegian School of Sport Sciences Norges musikkhøgskole Norwegian Academy of Music Det teologiske menighetsfakultet Norwegian School of Theology Høgskolen i Molde, vitenskapelig høgskole i Molde University College - Specialized logistikk (HiMolde) University in Logistics (HiMolde) 1.3 Høgskoler norsk engelsk Ansgar Teologiske Høgskole Ansgar College and Theological Seminary Dronning Mauds Minne Høgskole Queen Maud University College Forsvarets høgskole The Norwegian Defence University College (NDUC) Høgskolen i Innlandet (HINN) Inland Norway University of Applied Sciences - INN University Høgskulen på Vestlandet (HVL) Western Norway University of Applied Sciences (HVL) Høgskulen i Volda Volda University College Versjon 7.02.2019 Høgskolen i Østfold Østfold University College Høyskolen Kristiania Kristiania University College Kunsthøgskolen i Oslo Oslo National Academy of the Arts Lovisenberg diakonale høgskole Lovisenberg Diaconal University College Norsk Lærerakademi Høgskolen (NLA) NLA University College Politihøgskolen Norwegian Police University College Sámi allskuvla/Samisk høgskole Sámi University College VID vitenskapelige høgskole VID Specialized University Westerdals Oslo ACT Westerdals Oslo School of Arts, Communication and Technology 2. Forskningsorganisasjoner som omfattes av Retningslinjer for statlig basisfinansiering av forskningsinstitutter norsk engelsk Chr. Michelsens Institutt (CMI) Chr. Michelsen Institute (CMI) CICERO Senter for klimaforsking CICERO Center for International Climate and Environmental Research Forskningsstiftelsen FAFO Fafo Research Foundation Fridtjof Nansen Stiftelsen på Polhøgda (FNI) The Fridtjof Nansen Foundation at Polhøgda (FNI) Institutt for fredsforskning (PRIO) Peace Research Institute Oslo (PRIO) Institutt for samfunnsforskning (ISF) Institute for Social Research (ISF) Institutt for energiteknikk (IFE) Institute for Energy Technology (IFE) Møreforsking AS Møreforsking AS Nansen senter for miljø og fjernmåling Nansen Environmental and Remote Sensing Center Nofima AS Norwegian Institute of Food, Fisheries and Aquaculture Research AS Nordisk institutt for studier av innovasjon, Nordic Institute for Studies in Innovation, forskning og utdanning (NIFU) Research and Education (NIFU) Nordlandsforskning AS Nordland Research Institute Norges Geotekniske Institutt (NGI) Norwegian Geotechnical Institute (NGI) Norsk institutt for bioøkonomi (NIBIO) Norwegian Institute of Bioeconomy Research (NIBIO) Norsk institutt for kulturminneforskning Norwegian Institute for Cultural Heritage (NIKU) Research (NIKU) Norsk institutt for luftforskning (NILU) Norwegian Institute for Air Research (NILU) Norsk institutt for naturforskning (NINA) Norwegian Institute for Nature Research (NINA) Norsk institutt for vannforskning (NIVA) Norwegian Institute for Water Research (NIVA) Norsk Regnesentral Norsk senter for bygdeforsking (Bygdeforsking) Centre for Rural Research (Bygdeforsking) Norsk utenrikspolitisk institutt (NUPI) Norwegian Institute of International Affairs (NUPI) NORSAR NORSAR Northern Research Institute Narvik AS Northern Research Institute Narvik AS Norut Northern Research Institute AS Norut Northern Research Institute AS Versjon 7.02.2019 NTNU Samfunnsforskning NTNU Social Research RURALIS – Institutt for rural- og RURALIS – Institute for Rural and Regional regionalforskning Research Samfunns- og næringslivsforskning AS (SNF) Institute for Research in Economics and Business Administration (SNF) SINTEF AS SINTEF AS SINTEF Energi AS SINTEF Energy Research AS SINTEF Ocean AS SINTEF Ocean AS SINTEF Raufoss Manufacturing AS SINTEF Raufoss Manufacturing AS Stiftelsen Frischsenteret for The Ragnar Frisch Centre for Economic samfunnsøkonomisk forskning Research Telemarksforsking Telemark Research Institute Transportøkonomisk institutt (TØI) Institute of Transport Economics (TØI) Trøndelag Forskning og Utvikling AS Trøndelag R&D Institute AS Vestlandsforsking AS Western Norway Research Institute AS Veterinærinstituttet Norwegian Veterinary Institute Østfoldforskning AS Østfoldforskning AS Østlandsforskning AS Eastern Norway Research Institute AS 3. Helseforetak/sykehus med lovpålagt oppgaver innen forskning og utviklingsarbeid og private, ideelle sykehus som inngår i HODs målesystem for forskning norsk engelsk Akershus universitetssykehus HF Akershus University Hospital Beitostølen helsesportsenter Beitostølen Healthsports Center Betanien sykehus Betanien Hospital CatoSenteret Catosenteret Diakonhjemmet sykehus AS Diakonhjemmet Hospital AS Finnmarkssykehuset HF Finnmark Hospital Trust Frambu Senter for sjeldne Frambu Competence center for rare funksjonshemninger
Load more

Recommended publications
  • Annual Report 2020
    Annual Report Research Activity 2020 Division of Clinical Neuroscience University of Oslo and Oslo University Hospital 0 Contents Oslo University Hospital and the University of Oslo .................................................................................. 4 Division of Clinical Neuroscience .............................................................................................................. 4 Division of Clinical Neuroscience (NVR) Organizational Chart ................................................................... 5 Department of Physical Medicine and Rehabilitation Rehabilitation after trauma..................................................................................................................... 6 Group Leader: Nada Andelic Painful musculoskeletal disorders ........................................................................................................... 10 Group Leader: Cecilie Røe Department of Refractory Epilepsy - National Centre for Epilepsy Complex epilepsy ................................................................................................................................... 11 Group Leader: Morten Lossisus Department of Neurosurgery Neurovascular-Cerebrospinal Fluid Research Group ............................................................................. 17 Group Leader: Per Kristian Eide Oslo Neurosurgical Outcome Study Group (ONOSG) ................................................................................ 20 Group Leader: Eirik Helseth and Torstein Meling Vilhelm
    [Show full text]
  • Norwegian Journal of Epidemiology Årgang 27, Supplement 1, Oktober 2017 Utgitt Av Norsk Forening for Epidemiologi
    1 Norsk Epidemiologi Norwegian Journal of Epidemiology Årgang 27, supplement 1, oktober 2017 Utgitt av Norsk forening for epidemiologi Redaktør: Trond Peder Flaten EN NORSKE Institutt for kjemi, D 24. Norges teknisk-naturvitenskapelige universitet, 7491 Trondheim EPIDEMIOLOGIKONFERANSEN e-post: [email protected] For å bli medlem av Norsk forening for TROMSØ, epidemiologi (NOFE) eller abonnere, send e-post til NOFE: [email protected]. 7.-8. NOVEMBER 2017 Internettadresse for NOFE: http://www.nofe.no e-post: [email protected] WELCOME TO TROMSØ 2 ISSN 0803-4206 PROGRAM OVERVIEW 3 Opplag: 185 PROGRAM FOR PARALLEL SESSIONS 5 Trykk: NTNU Grafisk senter Layout og typografi: Redaktøren ABSTRACTS 9 Tidsskriftet er åpent tilgjengelig online: LIST OF PARTICIPANTS 86 www.www.ntnu.no/ojs/index.php/norepid Også via Directory of Open Access Journals (www.doaj.org) Utgis vanligvis med to regulære temanummer pr. år. I tillegg kommer supplement med sammendrag fra Norsk forening for epidemiologis årlige konferanse. 2 Norsk Epidemiologi 2017; 27 (Supplement 1) The 24th Norwegian Conference on Epidemiology Tromsø, November 7-8, 2017 We would like to welcome you to Tromsø and the 24th conference of the Norwegian Epidemiological Association (NOFE). The NOFE conference is an important meeting point for epidemiologists to exchange high quality research methods and findings, and together advance the broad research field of epidemiology. As in previous years, there are a diversity of topics; epidemiological methods, cardiovascular disease, diabetes, cancer, nutrition, female health, musculo-skeletal diseases, infection and behavioral epidemiology, all within the framework of this years’ conference theme; New frontiers in epidemiology. The conference theme reflects the mandate to pursue methodological and scientific progress and to be in the forefront of the epidemiological research field.
    [Show full text]
  • Perinatal Depression and Anxiety in Women with Multiple Sclerosis: a Population-Based Cohort Study
    Published Ahead of Print on April 21, 2021 as 10.1212/WNL.0000000000012062 Neurology Publish Ahead of Print DOI: 10.1212/WNL.0000000000012062 Perinatal Depression and Anxiety in Women with Multiple Sclerosis: A Population-Based Cohort Study Author(s): Karine Eid, MD1,2; Øivind Fredvik Torkildsen, MD PhD1,3; Jan Aarseth, PhD3,4,5; Heidi Øyen Flemmen, MD6; Trygve Holmøy, MD PhD7,8; Åslaug Rudjord Lorentzen, MD PhD9; Kjell-Morten Myhr, MD PhD1,3; Trond Riise, PhD3,5,10; Cecilia Simonsen, MD8,11; Cecilie Fredvik Torkildsen, MD1,12; Stig Wergeland, MD PhD2,3,4; Johannes Sverre 13,14 15 1,2 1,2 Willumsen, MD ; Nina Øksendal, MD ; Nils Erik Gilhus, MD PhD ; Marte-Helene Bjørk, MD PhD Note 1. The Article Processing Charge was funded by the Western Norway Regional Health Authority. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial- NoDerivatives License 4.0 (CC BY-NC-ND), which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. Neurology® Published Ahead of Print articles have been peer reviewed and accepted for publication. This manuscript will be published in its final form after copyediting, page composition, and review of proofs. Errors that could affect the content may be corrected during these processes. Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. Corresponding Author: Karine Eid [email protected] Affiliation Information for All Authors: 1.
    [Show full text]
  • Evaluation of Remdesivir and Hydroxychloroquine on Viral Clearance in Covid-19 Patients: Results from the NOR-Solidarity Randomised Trial
    Evaluation of remdesivir and hydroxychloroquine on viral clearance in Covid-19 patients: Results from the NOR-Solidarity Randomised Trial Andreas Barratt-Due1,2,9,*, Inge Christoffer Olsen3, Katerina Nezvalova Henriksen4,5, Trine Kåsine1,9, Fridtjof Lund-Johansen2,6, Hedda Hoel7,9,10, Aleksander Rygh Holten8,9, Anders Tveita11, Alexander Mathiessen12, Mette Haugli13, Ragnhild Eiken14, Anders Benjamin Kildal15, Åse Berg16, Asgeir Johannessen9,17, Lars Heggelund18,19, Tuva Børresdatter Dahl1,10, Karoline Hansen Skåra10, Pawel Mielnik20, Lan Ai Kieu Le21, Lars Thoresen22, Gernot Ernst23, Dag Arne Lihaug Hoff24, Hilde Skudal25, Bård Reiakvam Kittang26, Roy Bjørkholt Olsen27, Birgitte Tholin28, Carl Magnus Ystrøm29, Nina Vibeche Skei30, Trung Tran2, Susanne Dudman9,39, Jan Terje Andersen9,31, Raisa Hannula32, Olav Dalgard9,33, Ane-Kristine Finbråten7,34, Kristian Tonby9,35, Bjorn Blomberg36,37, Saad Aballi38, Cathrine Fladeby39, Anne Steffensen9, Fredrik Müller9,39, Anne Ma Dyrhol-Riise9,35, Marius Trøseid9,40 and Pål Aukrust9,10,40 on behalf of the NOR-Solidarity study group# 1Division of Critical Care and Emergencies, Oslo University Hospital, 0424 Oslo, Norway 2Division of laboratory Medicine, Dept. of Immunology, Oslo University Hospital, 0424 Oslo, Norway 3Department of Research Support for Clinical Trials, Oslo University Hospital, 0424 Oslo, Norway 4Department of Haematology, Oslo University Hospital, 0424 Oslo, Norway 5Hospital Pharmacies, South-Eastern Norway Enterprise, 0050 Oslo, Norway 6ImmunoLingo Covergence Centre, University
    [Show full text]
  • THE NORTHERN NORWAY REGIONAL HEALTH AUTHORITY (Helse Nord RHF)
    THE NORTHERN NORWAY REGIONAL HEALTH AUTHORITY (Helse Nord RHF) Northern Norway Regional Health Authority (Helse Nord RHF) is responsible for the public hospitals in northern Norway. The hospitals are organised in five trusts: • Finnmark Hospital Trust • University Hospital of Northern Norway Trust • Nordland Hospital Trust • Helgeland Hospital Trust • Hospital Pharmacy of North Norway Trust The trusts have their own management boards and are independent legal entities. Sector Healthcare Locations The four hospital Trusts are located in all of North Norway and Svalbard. Size Enterprise Data 5000 users since its launch in early 2011, will scale to approx. 12,500 users by the end of 2014. Company Website www.helse-nord.no For Reference Trond Kristiansen, E-Learning advisor. Nordland Hospital Trust Email - [email protected] Tel. +47 470 12 344 Øystein Lorentzen, Manager for IT Nordland Hospital Trust Email - [email protected] Tel. +47 900 40 566 THE NORTHERN NORWAY REGIONAL HEALTH AUTHORITY (Helse Nord RHF) Case Study Copyright © 2013 Docebo S.p.A. All rights reserved. Docebo is either a registered trademark or trademark of Docebo S.p.A. Other marks are the properties of their respective owners. To contact Docebo, please visit: www.docebo.com Company Customer Challenge The Northern Norway Regional Hospitals are often large and very Health Authority (Helse Nord RHF) complex organizations and is responsible for the public Docebo’s functionality fulfills many hospitals in northern Norway. of our needs right out of the box. The Regional Health Authority was Only basic customization with little established on the 1st January or no development is needed to "THROUGH COOPERATION 2002 when the central government implement the Docebo solution.
    [Show full text]
  • Improving Ambulance Coverage in a Mixed
    Delft University of Technology Improving ambulance coverage in a mixed urban-rural region in Norway using mathematical modeling van den Berg, Pieter L.; Fiskerstrand, Peter; Aardal, Karen; Einerkjær, Jørgen; Thoresen, Trond; Røislien, Jo DOI 10.1371/journal.pone.0215385 Publication date 2019 Document Version Final published version Published in PLoS ONE Citation (APA) van den Berg, P. L., Fiskerstrand, P., Aardal, K., Einerkjær, J., Thoresen, T., & Røislien, J. (2019). Improving ambulance coverage in a mixed urban-rural region in Norway using mathematical modeling. PLoS ONE, 14(4), 1-14. [e0215385]. https://doi.org/10.1371/journal.pone.0215385 Important note To cite this publication, please use the final published version (if applicable). Please check the document version above. Copyright Other than for strictly personal use, it is not permitted to download, forward or distribute the text or part of it, without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license such as Creative Commons. Takedown policy Please contact us and provide details if you believe this document breaches copyrights. We will remove access to the work immediately and investigate your claim. This work is downloaded from Delft University of Technology. For technical reasons the number of authors shown on this cover page is limited to a maximum of 10. RESEARCH ARTICLE Improving ambulance coverage in a mixed urban-rural region in Norway using mathematical modeling 1 2 3,4 2 Pieter L. van den BergID *, Peter Fiskerstrand
    [Show full text]
  • Day Surgery in Norway 2013–2017
    Day surgery in Norway 2013–2017 A selection of procedures December 2018 Helseatlas SKDE report Num. 3/2018 Authors Bård Uleberg, Sivert Mathisen, Janice Shu, Lise Balteskard, Arnfinn Hykkerud Steindal, Hanne Sigrun Byhring, Linda Leivseth and Olav Helge Førde Editor Barthold Vonen Awarding authority Ministry of Health and Care Services, and Northern Norway Regional Health Authority Date (Norwegian version) November 2018 Date (English version) December 2018 Translation Allegro (Anneli Olsbø) Version December 18, 2018 Front page photo: Colourbox ISBN: 978-82-93141-35-8 All rights SKDE. Foreword The publication of this updated day surgery atlas is an important event for several reasons. The term day surgery covers health services characterised by different issues and drivers. While ‘necessary care’ is characterised by consensus about indications and treatment and makes up about 15% of the health services, ‘preference-driven care’ is based more on the preferences of the treatment providers and/or patients. The preference-driven services account for about 25% of health services. The final and biggest group, which includes about 60% of all health services, is often called supply-driven and can be described as ‘supply creating its own demand’. Day surgery is a small part of the public health service in terms of resource use. However, it is a service that can be used to treat more and more conditions, and it is therefore becoming increasingly important for both clinical and resource reasons. How day surgery is prioritised and delivered is very important to patient treatment and to the legitimacy of the public health service. Information about how this health service is distributed in the population therefore serves as an important indicator of whether we are doing our job and whether the regional health authorities are fulfilling their responsibility to provide healthcare to their region’s population.
    [Show full text]
  • Catalytic Impact of Airports in Norway
    REPORT 1008 Nigel Halpern and Svein Bråthen CATALYTIC IMPACT OF AIRPORTS IN NORWAY Nigel Halpern and Svein Bråthen Catalytic impact of airports in Norway Report 1008 ISSN: 0806-0789 ISBN: 978-82-7830-150-0 Møreforsking Molde September 2010 Title Catalytic impact of airports in Norway Authors Nigel Halpern and Svein Bråthen Report number 1008 Project number 2229 Project name Catalytic impact of airports in Norway Project leader Nigel Halpern Source of funding Norwegian Ministry of Transport and Communications Report can be ordered from: Molde University College library Post box 2110, 6402 MOLDE Tel.: 71 21 41 61 Fax.: 71 21 41 60 email: [email protected] – www.himolde.no Number of pages 112 Price Kr 150,- ISSN 0806-0789 ISBN 978-82-7830-150-0 Abstract This study investigates the catalytic impact of airports in Norway. In particular, it investigates the impact that airports have on regional accessibility, social development and economic competitiveness. The findings are based on two phases of research. The first phase consists of desk research on the findings of previous studies in Norway and of original analysis of published data for Norway. The second phase consists of a case study on two airports in Norway; Ålesund Airport and Brønnøysund Airport. The case study compares the opinions of residents and businesses served by the respective airports and is based on the findings of a postal survey that was completed by over 2 000 residents and an online survey that was completed by over 350 businesses. The analysis finds that airports play an important role in securing the accessibility of regions in Norway.
    [Show full text]
  • Optique in Patient Safety
    The project has been defined as a strategic innovation project. Optique Summit IV, Sept. 15th 2016,@ University of Oxford South-Eastern Norway Regional Health Authority (HSØ) Health regions are 100% state owned trusts with full legal and financial responsibilities, their own board and their own CEO/management 10 hospital trusts Akershus University Hospital Trust, Ahus Oslo University Hospital Trust Innlandet Hospital Trust Sunnaas Hospital Trust Sørlandet Hospital Trust Ahus Telemark Hospital Trust Vestfold Hospital Trust Vestre Viken Hospital Trust Østfold Hospital Trust HSØ-area • 2.9 mill inhabitants • Budget: 79 billion NOK/ 8,5 billion € for hospital health care pr year Norway (totaly): • 78 000 employees in business • 5.2 mill inhabitants 2 Source: McKinsey analysis Akershus University Hospital (Ahus) Ahus is a Complete urban hospital – large share of immigrant population - A full service hospital – emergency, planned assistance – Serving all inhabitants of the catchment area - from newly born to geriatrics Ahus is Norway’s largest and most modern emergency assistance provider Ahus is a university hospital with fruitful research and development activities Ahus Area • 520,000 Inhabitants • 62,700 Inpatient stays, • 27,500 Day patient care • Budget: 7.5 billion NOK/ 0,95 billion € for hospital health care pr year • 9,250 employees in business Human touch and empathy – with professional skill UiO HSØ Optique in Healthcare is growing Health South-East has awarded strategic innovation funds to Akershus University Hospital (Ahus), by the Division Director Ivar Thor Jonsson for the project “Development of a semantic IT solution and ontology for clinical use in health care”. The project has been awarded 2MNOK and is defined as a strategic innovation project.
    [Show full text]
  • Hjerteforum Suppl
    hjerteforum Suppl. 2/ 2015 / 28. årgang IMPLEMENTATION OF NEW ECHOCARDIOGRAPHIC MODALITIES IN ROUTINE PRACTICE IN A GENERAL HOSPITAL – POCKET-SIZE CARDIAC ULTRASOUND AND 3 DIMENSIONAL ECHOCARDIOGRAPHY. Studies on feasibility and diagnostic accuracy VIDAR DE BOURG RUDDOX Thesis for the degree of Philosophiae Doctor Department of Cardiology, Vestfold Hospital Trust & University of Oslo, Faculty of Medicine Oslo 2015 TABLE OF CONTENTS 1 Acknowledgements ............................................................................................ 4 2 Synopsis ...............................................................................................................5 3 Scientific environment ...................................................................................... 6 4 List of Papers .......................................................................................................7 Paper I ..................................................................................................................................................7 Paper II ................................................................................................................................................7 Paper III ..............................................................................................................................................7 Paper IV ...............................................................................................................................................7 5 Abbreviations and Acronyms ...........................................................................
    [Show full text]
  • The Economic Burden of Tnfα Inhibitors and Other Biologic Treatments in Norway
    ClinicoEconomics and Outcomes Research Dovepress open access to scientific and medical research Open Access Full Text Article ORIGINAL RESEARCH The economic burden of TNFα inhibitors and other biologic treatments in Norway Jan Norum1 Objective: Costly biologic therapies have improved function and quality of life for patients Wenche Koldingsnes2 suffering from rheumatic and inflammatory bowel diseases. In this survey, we aimed to document Torfinn Aanes3 and analyze the costs. Margaret Aarag Antonsen4 Methods: In 2008, the total costs of tumor necrosis factor alpha inhibitors and other biologic Jon Florholmen5 agents in Norway were registered prospectively. In addition to costs, the pattern of use in the Masahide Kondo6 four Norwegian health regions was analyzed. The expenses were calculated in Norwegian krone and converted into Euros. 1Northern Norway Regional Results: The pattern of use was similar in all four regions, indicating that national guidelines Health Authority, Bodø, Norway; 2Department of Rheumatology, are followed. Whereas the cost was similar in the southeast, western, and central regions, the For personal use only. University Hospital of North Norway, expenses per thousand inhabitants were 1.56 times higher in the northern region. This indicates Tromsø, Norway; 3Drug Procurement that patients in the northern region experienced a lower threshold for access to these drugs. The Cooperation, Oslo, Norway; 4Hospital Pharmacy of North Norway Trust, gap in costs between trusts within northern Norway was about to be closed. The Departments Tromsø, Norway; 5Department of of Rheumatology and Gastroenterology had the highest consumption rates. Gastroenterology, University Hospital of North Norway, Tromsø, Norway; Conclusion: The total cost of biologic agents was significant.
    [Show full text]
  • A Model-Based Cost-Minimization Analysis As a Decision Tool in Obstetric Care in Helgeland, Northern Norway
    Global Journal of Health Science; Vol. 9, No. 1; 2017 ISSN 1916-9736 E-ISSN 1916-9744 Published by Canadian Center of Science and Education A Model-Based Cost-Minimization Analysis as a Decision Tool in Obstetric Care in Helgeland, Northern Norway Halvard Angelsen1, Jan Norum2,3, Villy Angelsen4, Fred A. Mürer5 & Randi Erlandsen5. 1 Department of Radiology, University Hospital of North Norway, Tromsø, Norway 2 Institute of Clinical Medicine, Faculty of Health Sciences, UiT - The Arctic University of Norway, Tromsø 3 Northern Norway Regional Health Authority trust, Bodø, Norway 4 Vestvågøy Community, Leknes, Norway 5 Helgeland hospital, Mo i Rana Correspondence: Jan Norum, Northern Norway Regional Health Authority trust, N-8038 Bodø, Norway. Tel: 47-95-404-205. E-mail: [email protected] Received: February 19, 2016 Accepted: April 18, 2016 Online Published: May 19, 2016 doi:10.5539/gjhs.v9n1p191 URL: http://dx.doi.org/10.5539/gjhs.v9n1p191 Abstract Background: Quality of care is of utmost importance in maternity care. Today, we base the choice of institution on risk factors. Recently, a Norwegian national plan introduced new guidelines concerning quality and staffing. Consequently, the hospital trusts had to increase the number of obstetricians and midwives and handle raised costs. One way to meet such challenges is to reduce the number of delivery units. Objectives: We aimed to clarify the costs and benefits of two alternative strategies in obstetric care in Helgeland hospital trust using a model-based cost-minimization analysis (CMA). Methods: The consequences, in terms of cost/savings and mothers´ time of travelling, by closing two midwife-administered maternity units (MAMUs) and keeping the two departments of obstetrics (DOGs) running was analyzed.
    [Show full text]